HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene

Lancet

Volumn 351, Issue 9095, 1998, Pages 14-18

  Quillent, Caroline ^a   Oberlin, Estelle ^b   Braun, Joséphine ^a   Rousset, Dominique ^b   Gonzalez Canali, Gustavo ^a   Métais, Patricia ^a   Montagnier, Luc ^b   Virelizier, Jean Louis ^b   Arenzana Seisdedos, Fernando ^b   Beretta, Alberto ^a  

^a SAINT JOSEPH HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MONONUCLEAR CELL; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR GENE; SEXUAL INTERCOURSE; STOP CODON; VIRUS RESISTANCE;

EID: 17044452367     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)09185-X     Document Type: Article

References (25)

1. 1 Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722-25.
2. 2 Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367-77.
3. 3 Biti R, French R, Young J, Bennetts B, Stewart G, Liang T. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat Med 1997; 3: 252-53.
4. 4 O'Brien TR, Winkler C, Dean W, et al. HIV-1 infection in a man homozygous for CCR5 A32. Lancet 1997; 349: 1219.
5. 5 Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C, for the Seroco Study Group. HIV-1 infection in an individual homozygous for CCR5Δ32. Lancet 1997; 349: 1219-20.
6. 6 Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 1996; 273: 1856-62.
7. 7 Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667-73.
8. 8 Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381: 661-66.
9. 9 Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272: 1955-58.
10. 10 Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR-5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85: 1135-48.
11. 11 Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993; 261: 1179-81.
12. 12 Doranz BJ, Rucker J,YiY, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996; 85: 1159-58.
13. 13 Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactors: functional cDNA cloning of a seven transmembrane, G protein-coupled receptor. Science 1996; 272: 872-77.
14. 14 Chameau P, Mirambeau G, Roux P, Paulous S, Buc H, Clavel F. HIV-1 reverse transcription: a termination step at the center of the genome. J Mol Biol 1994; 241: 651-62.
15. 15 Dragic T, Charneau P, Clavel F, Alizon M. Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol 1992; 68: 4794-802.
16. 16 Pleskoff O, Treboute C, Brelot A, Heveker N, Seman M, Alizon M. Chemokine receptor encoded by the human cytomegalovirus in a cofactor for HIV-1 entry. Science 1997; 276: 1874-78.
17. 17 Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/FUSIN and prevents infection by T-cell-line adapted HIV-1. Nature 1996; 382: 833-35.
18. 18 LiY, Hui H, Burgess CJ, et al. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J Virol 1992; 66: 6587-600.
19. 19 Zhang L, Huang Y, He T, Cao Y, Ho DD. HIV-1 subtype and second receptor use. Nature 1996; 383: 768.
20. 20 Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP1 a and MIP b as the major HIV suppressive factors produced by CDS+T cells. Science 1995; 270: 1811-15.
21. 21 Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996; 35: 3362-67.
22. 22 Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997; 277: 959-65.
23. 23 Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2: 1240-43.
24. 24 Michael NL, Chang G, Louie LG, et al. The role of the viral phenotype and CCR5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997; 3: 338-40.
25. 25 Zimmerman PA, Buckler-White A, Alkhatib G, et al. Inherited resistance to HIV-1 confered by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background and quantified risk. Mol Med 1997; 3: 23-36.